A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT05255458
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 122 participants
- Sponsor
- Registry
-
NCT05255458
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05255458. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-04 (actual); primary completion 2023-01-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia
- Condition
- Hyperlipidemia
- Intervention (Biological)
- AK102
- Intervention (Drug)
- Placebo
- Lead sponsor
- Akeso
Record details
- Record id
cardio:ct-nct05255458- Content hash
756b85a792fc531e14a7175722c6cef0bf217f5d34131caa7ffd772491a92bf9